keidkeidHome
10-QFiling Date: Apr 30, 2026

Bristol Myers (BMY) 10-Q (Apr 30, 2026)

bmy-20260331

View SEC Filing
ACC: 0000014272-26-000010
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$16.93B
Net Income$2.68B
Total Assets$86.48B
Stockholders' Equity$46.37B
Operating Cash Flow$1.10B

More filings from Bristol Myers (BMY)

  • 10-QBristol Myers (BMY) 10-Q · Jul 30, 2026Quarterly Report · ended 2026-06-30 · Rev $13.0B, NI $3.3B
  • 8-KBristol Myers (BMY) 8-K · Jul 30, 2026Earnings Release; Reg FD Disclosure; Financial Statements
  • 8-KBristol Myers (BMY) 8-K · May 8, 2026
  • 8-KBristol Myers (BMY) 8-K · Apr 30, 2026
  • 10-KBristol Myers (BMY) 10-K · Feb 11, 2026
  • 8-KBristol Myers (BMY) 8-K · Feb 5, 2026

Recent 10-Q filings from other companies

  • 10-QLennar 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $8.0B, NI $283.9M
  • 10-QNike (NKE) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $11.2B, NI $712.0M
  • 10-QDarden Restaurants (DRI) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-30 · Rev $3.2B, NI $233.4M
  • 10-QMccormick & (MKC) 10-Q · Oct 1, 2026Quarterly Report · ended 2026-08-31 · Rev $5.8B, NI $97.6M
  • 10-QConagra Brands (CAG) 10-Q · Sep 30, 2026Quarterly Report · ended 2026-08-30 · Rev $2.6B, NI $174.3M
B

Bristol Myers (BMY)

10-QBMY

Quarterly Report (10-Q)

Filing Date
Apr 30, 2026
Document
bmy-20260331
ACC
0000014272-26-000010
View SEC Filing

keid analysis is for reference only and does not constitute investment advice.